Artelo Biosciences Inc.

NASDAQ: ARTL · Real-Time Price · USD
10.06
-0.03 (-0.30%)
At close: Aug 15, 2025, 3:49 PM
10.25
1.89%
After-hours: Aug 15, 2025, 07:49 PM EDT

Artelo Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-10.54M -9.9M -10.11M -9.54M -10.96M -10.23M -9.93M -10.17M -9.95M -10.63M -10.29M -9.36M -8.86M -8.64M -8.56M -7.44M -6.58M -5.28M
Interest Income
8K 7K n/a n/a n/a n/a n/a n/a n/a 1K 2K 4K 4.54K 4.18K 3.43K 1.43K 889.00 253.00
Pretax Income
-10.5M -9.71M -9.83M -9.12M -10.44M -9.6M -9.29M -9.55M -9.44M -10.29M -10.08M -9.29M -8.85M -8.65M -8.55M -7.44M -6.58M -5.28M
Net Income
-10.5M -9.71M -9.83M -9.12M -10.44M -9.6M -9.29M -9.55M -9.44M -10.29M -10.08M -9.29M -8.85M -8.65M -8.55M -7.44M -6.58M -5.28M
Selling & General & Admin
4.48M 4.03M 4.12M 3.9M 4.05M 4.26M 4.23M 4.87M 5.16M 5.54M 5.96M 5.49M 5.45M 5.33M 5.05M 4.62M 4.1M 3.49M
Research & Development
6.06M 5.87M 5.99M 5.64M 6.9M 5.97M 5.7M 5.3M 4.79M 5.09M 4.32M 3.87M 3.41M 3.3M 3.5M 2.82M 2.48M 1.8M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
10.54M 9.9M 10.11M 9.54M 10.79M 10.06M 9.77M 10M 9.95M 10.63M 10.29M 9.36M 8.86M 8.64M 8.56M 7.44M 6.58M 5.28M
Interest Expense
-72K n/a n/a n/a n/a n/a n/a n/a 5K 5K 5K 5K n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
7.39M 9.9M 10.11M 9.54M 10.79M 10.06M 9.77M 10M 9.95M 10.63M 10.29M 9.36M 8.86M 8.64M 8.56M 7.44M 6.58M 5.28M
Income Tax Expense
n/a n/a n/a n/a 165K 165K 41K -99K -333K -355K -212K -76K -7.22K 13.15K -7.43K -4K -3.99K -2.57K
Shares Outstanding (Basic)
574K 3.28M 539.86K 3.23M 3.23M 3.2M 531.49K 491.5K 476K 476K 471.5K 474.83K 471.67K 470K 338.23K 338.23K 256.79K 188.67K
Shares Outstanding (Diluted)
574K 3.28M 539.86K 3.23M 3.23M 3.2M 531.49K 491.5K 476K 476K 472.17K 474.83K 471.73K 470.01K 338.23K 338.23K 256.79K 188.74K
EPS (Basic)
-13.68 -8.82 -8.88 -7.66 -8.14 -7.95 -7.89 -3.24 -3.2 -3.5 -3.48 -3.61 -2.88 -3.48 -4.43 -5.28 -5.32 -7.98
EPS (Diluted)
-13.68 -8.82 -8.88 -7.66 -8.14 -7.95 -7.89 -3.24 -3.2 -3.5 -3.48 -3.61 -2.88 -3.48 -4.43 -5.28 -5.32 -7.98
EBITDA
-10.54M -9.9M -10.11M -9.37M -8.01M -7.47M -7.29M -7.7M -10.26M -10.78M -10.29M -9.37M -8.86M -8.62M -8.56M -7.44M -6.58M -5.28M
EBIT
-7.39M -9.9M -10.11M -9.37M -8.17M -7.45M -7.15M -4.08M -4.08M -4.76M -4.42M -6.97M -8.86M -8.64M -8.56M -7.44M -6.58M -5.28M
Depreciation & Amortization
n/a n/a n/a n/a 2.61M 2.43M 2.31M 2.23M -353.92K -189.92K -45.92K 30.08K 3.23K 24.29K 4.35K 408.00 311.00 374.00